Sofosbuvir Completed Phase 1 / 2 Trials for Hepatitis C Viral Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01497327Open-Label Hepatic Impairment Study